河北医科大学学报 ›› 2024, Vol. 45 ›› Issue (8): 899-905.doi: 10.3969/j.issn.1007-3205.2024.08.006

• • 上一篇    下一篇

肺泡复苏策略联合右美托咪定支气管内给药对老年行胸腔镜下食管癌根治术患者围术期炎性因子及肺氧合功能的影响

  

  1. 1.河北省邢台市人民医院麻醉科, 河北 邢台 054001;2.河北省邢台市人民医院肿瘤科,河北 邢台 054001

  • 出版日期:2024-08-25 发布日期:2024-09-04
  • 作者简介:解静(1985-),女,河北邢台人,河北省邢台市人民医院主治医师,医学硕士,从事临床麻醉学研究。
  • 基金资助:
    邢台市重点研发计划项目(2021ZC145)

Effects of pulmonary alveolar recruitment strategy combined with intrabronchial administration of dexmedetomidine on perioperative inflammatory factors and pulmonary oxygenation in elderly patients undergoing thoracoscopic radical resection for esophageal cancer

  1. 1.Department of Anesthesiology,  Xingtai People′s Hospital, Hebei Province, Xingtai 054001, China; 
    2.Department of Oncology, Xingtai People′s Hospital, Hebei Province, Xingtai 054001, China
  • Online:2024-08-25 Published:2024-09-04

摘要: 目的 探讨老年患者胸腔镜下行食管癌根治术围手术期间,肺泡复苏策略(alveolar recruitment strategy,ARS)联合支气管内给予右美托咪定对其肺氧合功能及炎性因子的影响。
方法 选择河北省邢台市人民医院择期拟在全身麻醉下行胸腔镜下食管癌根治手术患者60例,年龄55~75岁,美国麻醉医师协会(American Society of Anesthesiologists,ASA)分级Ⅰ~Ⅱ级。随机分为3组,支气管内给药组(A组),静脉给药组(B组),ARS+支气管内右美托咪定组(C组)。C组患者,在术前术中术后实施3次肺泡复苏ARS,即连续10次手控呼吸,每次持续时间>15 s,使吸气平台压达到40 cmH2O(1 cmH2O=0.098 kPa),完成后实施容量控制通气模式,1〖DK〗∶E=1〖DK〗∶2,VT 6 mL/kg,吸入氧气浓度(fraction of inspiration O2,FiO2)80%,RR 14次/min。第1次ARS在手术开始单肺通气前;第2次ARS在手术进行90 min后;第3次ARS手术结束后。3次进行ARS的同时支气管内给予浓度10 mg/L,剂量1.0 μg/kg的右美托咪定。B组麻醉开始前10 min内输入1.0 μg/kg剂量的右美托咪定,随后调整剂量以0.5 μg·kg-1·h-1持续输注至手术结束。A组同C组在同一时间段(即单肺通气前,手术进行90 min,手术结束后)支气管内给予同等浓度和剂量的右美托咪定。2组手术开始后常规单肺通气(同C组),术前术中术后均不进行肺泡复苏策略。分别在麻醉诱导前T0,单肺通气即刻T1,单肺通气60 min T2,单肺通气90 min T3,术后24 h T4各时间点,记录白细胞介素6(interleukin-6,IL-6)浓度,氧分压(partial pressure of oxygen,PaO2),呼末CO2,计算肺内分流率Qs/Qt,记录统计围术期的不良反应率[低血压即术中平均动脉压(mean artery pressure,MAP)]下降幅度超过基础值30%时、心动过缓发生率即HR<50次/min且持续时间>10 min、肺部感染即出现呼吸道分泌物增多肺部出现支气管啰音或吸痰次数增多且胸片检查出现发展且持续存在的肺部浸润、低氧血症即PaO2<80 mmHg(1 mmHg=0.133 kPa)、肺不张即胸片检查肺密度增高影。
结果 对于IL-6、IL-8指标,各组均在T3均呈升高趋势,在T4均呈下降趋势,组间、时点间、组间·时点间交互作用差异均有统计学意义(P<0.05)。对于PaO2指标,各组均在T1均呈升高趋势,A和B组在T2均呈下降趋势,各组在T3、T4均呈下降趋势,组间、时点间、组间·时点间交互作用差异均有统计学意义(P<0.05)。对于CO2指标,在T1点,A和C组均呈下降趋势,B组呈升高趋势;在T2点,B组呈下降趋势,C组呈升高趋势;在T3点,A和C组均呈下降趋势,B组呈升高趋势;在T4点,A组均呈升高趋势,B组和C组呈下降趋势,组间、时点间、组间·时点间交互作用差异均有统计学意义(P<0.05)。对于肺内分流的Qs/Qt指标,在T1点,A、B、C组均呈下降趋势;在T2点,A、B、C组呈升高趋势;在T3点,A、B、C组呈升高趋势;在T4点,A、B组和C组呈下降趋势,组间、时点间、组间·时点间交互作用差异均有统计学意义(P<0.05)。3组相比,B组出现低血压和心动过缓的不良反应发生率高于A组与C组,且差异有统计学意义(P<0.05)。而术后肺部并发症,A组和B组均大于C组,且差异有统计学意义(P<0.05)。A组和C组之间比较,出现低血压和心动过缓的不良反应发生率差异无统计学意义(P>0.05)。
结论 ARS联合支气管内给予右美托咪定更能提高胸腔镜食管癌根治术患者围手术期肺氧合功能,减少肺内分流,减轻炎症反应,降低并发症的发生。


关键词: 食管肿瘤, 胸腔镜检查, 右美托咪啶

Abstract: 〓Objective To investigate the effects of alveolar recruitment strategy (ARS) combined with intrabronchial administration of dexmedetomidine on pulmonary oxygenation and inflammatory factors in elderly patients undergoing thoracoscopic radical resection for esophageal cancer. 
Methods A total of 60 patients, aged 55-75 years and classified as American Society of Anesthesiologists (ASA) grade Ⅰ-Ⅱ, were selected for elective thoracoscopic radical surgery for esophageal cancer under general anesthesia in Xingtai People′s Hospital. They were randomly divided into three groups: intrabronchial administration group (group A), intravenous administration group (group B), and ARS+ intrabronchial dexmedetomidine group (group C). In group C, ARS was performed before, during and after surgery, that is, 10 consecutive manual breaths, with the duration of >15 s each time, enabling the inspiratory platform pressure to reach 40 cmH2O, followed by implementation of the volume-controlled ventilation mode, 1〖DK〗∶E=1〖DK〗∶2, VT 6 mL/kg, fraction of inspiration O2 (FiO2) 80%, RR 14 times/min. The first ARS was performed before single lung ventilation after surgery, the second ARS was performed at 90 min after the initiation of operation, and the third ARS was performed after operation. The ARS was performed for three times simultaneously with intravenous administration of dexmedetomidine at a concentration of 10 μg/mL and a dose of 1.0 μg/kg. Group B received a dose of 1.0 μg/kg dexmedetomidine within 10 min before initiation of anesthesia, and then the dose was adjusted to 0.5 μg·kg-1·h-1 until the end of the operation. Group A and group C were given the same concentration and dose of dexmedetomidine in the bronchus at the same period of time (that is, before single lung ventilation, at 90 min after surgery, and after surgery). Routine single lung ventilation (the same as group C) was performed in both groups after operation, and no ARS was performed before, during and after operation. Before anesthesia induction (T0), immediately after single lung ventilation (T1), at 60 min after single lung ventilation (T2), at 90 min after single lung ventilation (T3), and at 24 h after operation (T4), interleukin 6 (IL-6) concentration, partial pressure of oxygen (PaO2), and end-expiratory CO2 were recorded, intrapulmonary shunt rate Qs/Qt was calculated, and perioperative adverse reaction rate [hypotension, i.e., intraoperative mean artery pressure (MAP) decrease of more than 30%], incidence of bradycardia, i.e. HR less than 50 times/min and duration greater than 10 min, pulmonary infection, i.e., increased respiratory secretions, pulmonary bronchial rales or increased sputum aspiration, progressive and persistent pulmonary infiltration by chest radiography, hypoxemia, i.e. PaO2<80 mmHg (1 mmHg=0.133 kPa), atelectasis, namely, increased lung density on chest X-ray examination was recorded. 

Results IL-6 and IL-8 indexes showed an increasing trend at T3 and a decreasing trend at T4 in all groups, and there were significant differences in interaction betwen groups, time points, and time points between groups (P<0.05). PaO2 index showed an increasing trend at T1 in all groups, groups A and B showed a decreasing trend at T2, and all groups showed a decreasing trend at T3 and T4. There were significant differences in interaction betwen groups, time points, and time points between groups (P<0.05). CO2 index showed a downward trend at T1 in both groups A and C, but an upward trend in group B. At T2, group B showed a downward trend while group C showed an upward trend. At T3, both groups A and C showed a decreasing trend, while group B showed an increasing trend. At T4 point, A group showed an increasing trend, while B group and C showed a decreasing trend, and there were significant differences in interaction between groups, time points, and time points between groups (P<0.05). For the intrapulmonary shunt rate Qs/Qt, groups A, B and C showed a downward trend at T1, while groups A, B and C showed an upward trend at T2; groups A, B and C showed an upward trend at T3, and groups A, B and C showed a downward trend at T4, with significant differences in interaction between groups, time points and time points between groups (P<0.05). For the comparison among the three groups, the incidence of hypotension and bradycardia in group B was higher than that in group A and group C, and the difference was statistically significant (P<0.05). The postoperative pulmonary complications in groups A and B were higher than those in group C, and the difference was statistically significant (P<0.05). There was no significant difference in the incidence of hypotension and bradycardia between group A and group C (P>0.05). 
Conclusion ARS combined with intrabronchial administration of dexmedetomidine can improve perioperative pulmonary oxygenation function, reduce intrapulmonary shunt, alleviate inflammatory response, and reduce complications in patients undergoing thoracoscopic radical resection of esophageal cancer. 


Key words: esophageal neoplasms, thoracoscopy, dexmedetomidine